Business Wire

Thales Unveils PureFlyt, the Brain of Tomorrow’s Aircraft

25.11.2019 21:33:00 EET | Business Wire | Press release

Share

Innovdays -Thales is unveiling PureFlyt, the Flight Management System (FMS) of the future, specifically designed to efficiently manage aircraft in a connected aerospace ecosystem and in increasingly crowded skies. Indeed, with the global commercial aircraft fleet forecast to double by 2030, and the use of drones set to rapidly grow, we will be entering an era in which millions of aircraft movements are recorded each day.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191125005715/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

© Thales

Combining extensive knowledge of Avionics, Connectivity, Air Traffic management and 40-year Flight Management System expertise, Thales has developed PureFlyt, an entirely connected FMS, designed to offer airframers and airlines the best combination of safety, security, and fuel and operations efficiency. PureFlyt will allow crews to make better decisions using more sources of information, will bring improved performance and reactivity to the aircraft during complex phases of flight and will calculate alternative trajectories in real time to propose or react quickly to changes of plan. Providing pilots with the right information at the right time heightens trust in the computed trajectory, enhancing efficiency and reducing pilot workload throughout all flight phases.

One of the core innovations making PureFlyt a game changer in the FMS world is its ability to draw on both onboard and open-world data, such as weather information. By combining the integrity of the FMS and the agility and power of Electronic Flight Bag flight functionalities, aircraft trajectory can be permanently controlled, adapted and enhanced, resulting in optimised flight, decreased fuel consumption and improved passenger comfort.

While being a technological breakthrough, PureFlyt enjoys an unparalleled maturity level. Using massive testing and artificial intelligence technologies to simulate 2 billion test cases enabled accumulating an invaluable experience, equivalent of 100 million actual flight hours.

Cyber-secure by design, PureFlyt has also been designed to be future-proof, accommodating the implementation of concepts such as the Initial 4D (I4D) trajectory management methods currently being researched by SESAR (Single European Sky ATM Research) in the EU and NextGen in the US. By increasing the accuracy of flight in four dimensions, the fourth dimension being time, PureFlyt will enable more effectiveness in maintaining optimal distance between aircraft, particularly in the demanding phases of departure and approach.

PureFlyt will be available for entry into service in 2024, for both linefit and retrofit.

“In the air, the digital revolution has only just begun. A paradigm shift in onboard cockpit electronics is taking place in the connected airspace and PureFlyt is at the forefront of this digital new age, leading the next generation of Flight Management System that truly makes the aircraft a node of connectivity. By computing and sharing vast amounts of data, PureFlyt will make flights safer, greener, easier for the pilots to manage, more profitable for airlines and, all this, ultimately for the full benefits of passengers” declared Jean-Paul Ebanga, Thales Vice-President Flight Avionics.

For more information please visit:
https://www.thalesgroup.com/en/group/magazine/quantum-leap-flight-management

About Thales

The people we all rely on to make the world go round – they rely on Thales. Our customers come to us with big ambitions: to make life better, to keep us safer. Combining a unique diversity of expertise, talents and cultures, our architects design and deliver extraordinary high technology solutions. Solutions that make tomorrow possible, today. From the bottom of the oceans to the depth of space and cyberspace, we help our customers think smarter and act faster - mastering ever greater complexity and every decisive moment along the way.

Thales generated revenues of €19 billion in 2018 with 80,000 employees in 68 countries.

PLEASE VISIT

Thales Group
Thales Press
Download HD photos

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

PRESS
Thales, Media Relations
Civil Aerospace
Giaime Porcu
+33 1 57 77 92 18
giaime.porcu@thalesgroup.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 21:00:00 EET | Press release

Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham, MSc, MD, FRCPC, dermatologist, SKiN Centre for Dermatology, Peterborough, Ontario, Canada, principal investigator for the Latitude PsO studies and presenting author. “These efficacy and safety results show it’s possible for a once-daily pill to deliver rapid, lasting skin clearance, highlighting the potential of zasoc

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 21:00:00 EET | Press release

Incyte (Nasdaq:INCY) today announced 54-week data evaluating the safety and efficacy of povorcitinib (INCB54707), an oral small-molecule highly-selective JAK1 inhibitor, from the pivotal Phase 3 STOP-HS clinical trial program in adult patients (≥18 years) with moderate to severe hidradenitis suppurativa (HS). The late-breaking oral presentation of these data is taking place at the 2026 American Academy of Dermatology (AAD) Annual Meeting, being held March 27-31, 2026, in Denver (Session: S034 – Late-Breaking Research: Session 2. Saturday, March 28, 2026, 1:00-4:00 p.m. MT). “The 54-week results from the STOP-HS program deliver compelling, long-term evidence supporting the potential of povorcitinib for patients with moderate to severe HS,” said Pablo J. Cagnoni, M.D., President and Global Head of Research and Development, Incyte. “Across both studies, povorcitinib demonstrated substantial and durable improvements over time in key measures of treatment success and meaningful clinical ben

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 17:00:00 EET | Press release

Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-breaking session at the 2026 American Academy of Dermatology (AAD) Annual Meeting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260328320362/en/ Atopic dermatitis is the most common inflammatory skin disorder in children, yet treatment options in the moderate-to-severe pediatric setting are limited.5 The disease can have a significant impact on quality of life for both the patients and their loved ones, with persistent itch and recurrent skin lesions often disrupting sleep, school and relationships.5-8 “Atopic dermatitis can affect many aspects of children’s lives including schoolwork, emotional development

Angelalign Technology (6699.HK) Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 21:56:00 EET | Press release

Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti

Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 19:46:00 EET | Press release

Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye